| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | -6.92% | +0.55% | -7.47% | -11.94% | — |
| 14d | 3 | +66.67% | -4.55% | +2.08% | -6.63% | -13.02% | — |
| 30d | 3 | +100.00% | -13.53% | +4.34% | -17.87% | -24.29% | — |
| 60d | 3 | +100.00% | -30.27% | +4.52% | -34.79% | -48.38% | — |
| 90d | 3 | +100.00% | -31.47% | +8.19% | -39.66% | -56.86% | — |
| 180d | 3 | +100.00% | -53.86% | +16.07% | -88.05% | -88.05% | — |
| 1y | 3(1 pending) | +100.00% | -68.86% | +34.29% | -103.16% | -103.16% | — |
| 2y | 3(1 pending) | +100.00% | -85.06% | +48.66% | -133.72% | -133.72% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 3,413 | $14.25 | $48.6K | 374,854 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 1,650 | — | — | 373,042 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 5,225 | — | — | 378,267 | Feb 12, 2026 | Feb 13, 2026 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 2,390 | $14.23 | $34.0K | 371,392 | Dec 5, 2025 | Dec 5, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 753 | $14.12 | $10.6K | 373,782 | Dec 1, 2025 | Dec 3, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Nov 25, 2025 | Nov 26, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 4,324 | $5.59 | $24.2K | 374,535 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 9,750 | — | — | 378,859 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 2,591 | $8.06 | $20.9K | 369,109 | Dec 6, 2024 | Dec 10, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 1,595 | $8.60 | $13.7K | 371,700 | Dec 1, 2024 | Dec 3, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 87,000 | — | — | 87,000 | Nov 27, 2024 | Nov 27, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 3,680 | — | — | 374,375 | Feb 12, 2024 | Feb 14, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Chief Scientific Officer | 1,080 | $12.41 | $13.4K | 373,295 | Feb 12, 2024 | Feb 14, 2024 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP, R&D & CSO | 2,412 | $9.63 | $23.2K | 370,695 | Dec 5, 2023 | Dec 6, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP, R&D & CSO | 1,595 | $9.49 | $15.1K | 373,107 | Dec 1, 2023 | Dec 5, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 86,000 | — | — | 86,000 | Nov 22, 2023 | Nov 22, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 13,925 | $14.00 | $194.9K | 388,627 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 13,925 | — | — | 0 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 269 | $43.92 | $11.8K | 388,358 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 13,656 | $44.46 | $607.1K | 374,702 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 7,752 | $52.77 | $409.1K | 374,702 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 10,250 | — | — | 369,437 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 13,017 | — | — | 382,454 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 1,055 | $44.33 | $46.8K | 359,187 | Dec 1, 2022 | Dec 5, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Nov 23, 2022 | Nov 28, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 21,000 | — | — | 360,242 | Nov 23, 2022 | Nov 28, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 615 | — | — | 337,776 | Feb 14, 2022 | Feb 15, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 2,419 | — | — | 340,195 | Feb 14, 2022 | Feb 15, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 953 | $62.49 | $59.6K | 339,242 | Feb 14, 2022 | Feb 15, 2022 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 557 | $87.68 | $48.8K | 337,161 | Dec 1, 2021 | Dec 3, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 28,400 | — | — | 28,400 | Nov 19, 2021 | Nov 23, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 6,800 | — | — | 337,718 | Nov 19, 2021 | Nov 23, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 4,872 | — | — | 0 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 3,672 | $11.77 | $43.2K | 326,046 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 5,149 | — | — | 0 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 4,872 | $11.77 | $57.3K | 330,918 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 5,149 | $14.18 | $73.0K | 322,374 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 3,672 | — | — | 0 | Jan 26, 2021 | Jan 28, 2021 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 5,250 | — | — | 0 | Dec 15, 2020 | Dec 16, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 5,250 | — | — | 318,765 | Dec 15, 2020 | Dec 16, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 1,540 | $42.52 | $65.5K | 317,225 | Dec 15, 2020 | Dec 16, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 7,600 | — | — | 313,515 | Nov 20, 2020 | Nov 20, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 30,800 | — | — | 30,800 | Nov 20, 2020 | Nov 20, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 1,089 | $52.76 | $57.5K | 305,915 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 487 | — | — | 304,079 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 2,925 | — | — | 307,004 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 2,331 | $63.88 | $148.9K | 303,592 | Dec 16, 2019 | Jan 6, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | PURCHASE Sr. VP & CSO | 5,250 | — | — | 305,923 | Dec 16, 2019 | Jan 6, 2020 ↗ | View → |
| ENTA ENANTA PHARMACEUTICALS INC | SALE Sr. VP & CSO | 5,250 | — | — | 5,250 | Dec 16, 2019 | Jan 6, 2020 ↗ | View → |